fbpx

Are you living with lupus?

Learn about a no-cost investigational treatment that may improve symptoms of moderate-to-severe active Systemic Lupus Erythematosus (SLE).

Systemic Lupus Erythematosus (SLE) Research Study

Systemic Lupus Erythematosus (SLE) is an autoimmune disease affecting multiple organs, with symptoms like arthritis, neurological issues, and organ disorders. While current treatments rely on corticosteroids and immunosuppressants, they pose toxicity risks. Researchers are exploring targeted therapies for safer, more effective treatment.

If you suffer from moderate-to-severe lupus, you might qualify for a research study on an investigational medication. This medication works by blocking certain proteins in the immune system that are thought to impact lupus disease.

The study is being conducted at select locations across the U.S. Eligible participants will receive all study-related care at no cost. Travel and time reimbursement may also be available.

FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA

  • Are between the ages of 18 to 70
  • Have had moderate-to-severe Systemic Lupus Erythematosus for more than 6 months
  • Currently receive stable dose treatment for lupus, such as corticosteroids or antirheumatic
  • Are not pregnant, breastfeeding, or planning to become pregnant

About the Study

The study will examine an investigational medication for moderate-to-severe Systemic Lupus Erythematosus (SLE). This clinical study will last up to 57 weeks, with a screening period, treatment period and post-treatment follow-up. The medication will be taken orally twice per day for the study treatment period.

Participation is at no cost and includes all study-related medical examinations, ECGs, clinical photography, laboratory work, questionnaires, optional genetic testing and various evaluations conducted by medical investigators. Additionally, you may receive compensation for the time and travel required to participate.

Why Participate?

If you have moderate-to-severe Systemic Lupus Erythematosus (SLE), you may qualify for a new research study of an investigational medication.
If you qualify, you will receive:

No-cost Study Care

You will receive study-related care from experienced doctors, nurses, and research staff.

Exams

The study will include physical examinations, ECGs, laboratory work, clinical photography, optional genetic testing and other examination visits with a trained investigator.

Compensation

You might be eligible to receive compensation for your time and travel.

Chat With a Research Coordinator

Fill out the form below to determine if you are eligible. If you meet the initial criteria, a research team member from a location near you will contact you. If you don’t qualify now, please still submit the form. The study criteria may change, and you could become eligible then.

© 2025 Accelerate Recruitment | Privacy Policy | Legal Notice